You are here: Industry Insights > SARS-CoV-2

News List

Premas Biotech’s COVID-19 vaccine candidate sees neutralising immune response in animal studies expresspharma
August 28, 2020
The company announced that it is in talks with regulatory authorities for human trials of its triple antigen vaccine.
Europe's largest initiative launches to accelerate therapy development for COVID-19 and future coronavirus threats worldpharmanews
August 27, 2020
CARE (Corona Accelerated R&D in Europe) a new consortium supported by the Innovative Medicines Initiative (IMI) public-private partnership announced its launch to accelerate the discovery and development of urgently needed medicines to treat SARS-CoV-2...
Blocking cellular communication stops SARS-CoV-2 worldpharmanews
August 27, 2020
In the transmission of signals within the cell which, for example, stimulate cell growth or trigger metabolic processes, phosphate groups play an important biochemical role.
Scancell receives funding for COVID-19 vaccine development pharmatimes
August 27, 2020
Scancell Holdings has secured funding of around £2 million from Innovate UK to initiate a Phase I clinical trial of an experimental SARS-CoV-2 vaccine.
First coronavirus re-infection reported in Hong Kong, S.A.R., China pharmatimes
August 26, 2020
Researchers in Hong Kong, S.A.R., China claim to have documented the first confirmed case of coronavirus reinfection.
Beckman Coulter Launches SARS-CoV-2 IgM Antibody Test and will begin shipping to U.S. Diagnostics Labs prnewswire
August 25, 2020
Beckman Coulter, a clinical diagnostics leader, today announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay.
Nasal vaccine against COVID-19 prevents infection in mice worldpharmanews
August 25, 2020
Scientists at Washington University School of Medicine in St. Louis have developed a vaccine that targets the SARS-CoV-2 virus, can be given in one dose via the nose and is effective in preventing infection in mice susceptible to the novel coronavirus.
COVID-19 Vaccine Candidate Enters Phase 1 Study with First Healthy Volunteer americanpharmaceuticalreview
August 25, 2020
ReiThera has announced the first healthy volunteer has been dosed in a Phase 1 study of the Company's vaccine candidate (GRAd-COV2) against the novel coronavirus (SARS-CoV-2).
Zymo Research Granted CE IVD Mark for Quick SARS-CoV-2 rRT-PCR Kit americanpharmaceuticalreview
August 24, 2020
Zymo Research has been granted the CE IVD Mark for its Quick SARS-CoV-2 rRT-PCR Kit. To obtain this certification the product had to comply with the Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in ...
Preclinical Study Finds Nafamostat Blocks SARS-CoV-2 Infection in Human Lung Cells americanpharmaceuticalreview
August 24, 2020
A preclinical study testing the generic drug nafamostat in human cells shows it can help block SARS-CoV-2 infection.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page